Murilo Freitas – Page 50 – PRAIS 2.0

Safety and Quality Concerns with Getinge Cardiovascular Devices – Letter to Health Care Providers

Murilo Freitas - 04:00, 7 de May de 2024311

Health care providers and facilities should begin to transition away from these devices and seek alternatives.

http://www.fda.gov/medical-devices/letters-health-care-providers/safety-and-quality-concerns-getinge-cardiovascular-devices-letter-health-care-providers

FDA Roundup: May 7, 2024

Murilo Freitas - 20:09, 6 de May de 2024338

FDA Roundup: May 7, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-7-2024

FDA Roundup: May 3, 2024

Murilo Freitas - 19:28, 2 de May de 2024381

FDA Roundup: May 3, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-3-2024

FDA Clarifies Approach to Genomic Alterations in Animals

Murilo Freitas - 13:20, 30 de April de 2024371

FDA Clarifies Approach to Genomic Alterations in Animals
http://www.fda.gov/news-events/press-announcements/fda-clarifies-approach-genomic-alterations-animals

FDA Roundup: April 30, 2024

Murilo Freitas - 19:19, 29 de April de 2024382

FDA Roundup: April 30, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-april-30-2024

FDA to Hold Listening Session as Part of Broader Work to Optimize Use of, and Processes for, Advisory Committees

Murilo Freitas - 14:58, 28 de April de 2024456

FDA to Hold Listening Session as Part of Broader Work to Optimize Use of, and Processes for, Advisory Committees
http://www.fda.gov/news-events/press-announcements/fda-hold-listening-session-part-broader-work-optimize-use-and-processes-advisory-committees

FDA Takes Action Aimed at Helping to Ensure the Safety and Effectiveness of Laboratory Developed Tests

Murilo Freitas - 13:50, 28 de April de 2024382

FDA Takes Action Aimed at Helping to Ensure the Safety and Effectiveness of Laboratory Developed Tests
http://www.fda.gov/news-events/press-announcements/fda-takes-action-aimed-helping-ensure-safety-and-effectiveness-laboratory-developed-tests

SonarMed Inc. Recalls Airway Monitors Due to a Software Anomaly Resulting in Failure to Detect a Partial Obstruction in 2.5mm Sensors and Up To 3mm Distal to the Sensor Tip

Murilo Freitas - 04:00, 28 de April de 2024419

SonarMed Airway monitors recalled for a software issue where it fails to detect partial obstructions in 2.5mm sensors and within 3mm of sensor tip.

http://www.fda.gov/medical-devices/medical-device-recalls/sonarmed-inc-recalls-airway-monitors-due-software-anomaly-resulting-failure-detect-partial

SonarMed Inc. Recalls Airway Acoustic Sensors Due to a Restricted Inner Diameter of Airway Causing Suction Catheter Passage Difficulty

Murilo Freitas - 04:00, 28 de April de 2024371

SonarMed Airway acoustic sensors recalled due to a restricted inner diameter resulting in difficulty passing a suction catheter through the sensor.

http://www.fda.gov/medical-devices/medical-device-recalls/sonarmed-inc-recalls-airway-acoustic-sensors-due-restricted-inner-diameter-airway-causing-suction

FDA Roundup: April 26, 2024

Murilo Freitas - 19:08, 25 de April de 2024509

FDA Roundup: April 26, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-april-26-2024

PRAIS 2.0